387 related articles for article (PubMed ID: 37770897)
1. Meta-analysis of senescent cell secretomes to identify common and specific features of the different senescent phenotypes: a tool for developing new senotherapeutics.
Oguma Y; Alessio N; Aprile D; Dezawa M; Peluso G; Di Bernardo G; Galderisi U
Cell Commun Signal; 2023 Sep; 21(1):262. PubMed ID: 37770897
[TBL] [Abstract][Full Text] [Related]
2. The implication of ROCK 2 as a potential senotherapeutic target via the suppression of the harmful effects of the SASP: Do senescent cancer cells really engulf the other cells?
Şimay Demir YD; Özdemir A; Sucularlı C; Benhür E; Ark M
Cell Signal; 2021 Aug; 84():110007. PubMed ID: 33845155
[TBL] [Abstract][Full Text] [Related]
3. Cellular senescence in bone.
Farr JN; Khosla S
Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
[TBL] [Abstract][Full Text] [Related]
4. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
[TBL] [Abstract][Full Text] [Related]
5. Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype.
Malaquin N; Martinez A; Rodier F
Exp Gerontol; 2016 Sep; 82():39-49. PubMed ID: 27235851
[TBL] [Abstract][Full Text] [Related]
6. Senotherapeutics in Cancer and HIV.
Sánchez-Díaz L; Espinosa-Sánchez A; Blanco JR; Carnero A
Cells; 2022 Apr; 11(7):. PubMed ID: 35406785
[TBL] [Abstract][Full Text] [Related]
7. Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy.
Liu H; Xu Q; Wufuer H; Li Z; Sun R; Jiang Z; Dou X; Fu Q; Campisi J; Sun Y
Aging Cell; 2024 Jan; 23(1):e13921. PubMed ID: 37475161
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria-targeted senotherapeutic interventions.
Atayik MC; Çakatay U
Biogerontology; 2022 Aug; 23(4):401-423. PubMed ID: 35781579
[TBL] [Abstract][Full Text] [Related]
9. Exploring the role of senescence inducers and senotherapeutics as targets for anticancer natural products.
Mamun AA; Sufian MA; Uddin MS; Sumsuzzman DM; Jeandet P; Islam MS; Zhang HJ; Kong AN; Sarwar MS
Eur J Pharmacol; 2022 Aug; 928():174991. PubMed ID: 35513016
[TBL] [Abstract][Full Text] [Related]
10. Modulation of fracture healing by senescence-associated secretory phenotype (SASP): a narrative review of the current literature.
Zhao S; Qiao Z; Pfeifer R; Pape HC; Mao K; Tang H; Meng B; Chen S; Liu H
Eur J Med Res; 2024 Jan; 29(1):38. PubMed ID: 38195489
[TBL] [Abstract][Full Text] [Related]
11. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
[TBL] [Abstract][Full Text] [Related]
12. Unbiased analysis of senescence associated secretory phenotype (SASP) to identify common components following different genotoxic stresses.
Özcan S; Alessio N; Acar MB; Mert E; Omerli F; Peluso G; Galderisi U
Aging (Albany NY); 2016 Jul; 8(7):1316-29. PubMed ID: 27288264
[TBL] [Abstract][Full Text] [Related]
13. Progression of irradiated mesenchymal stromal cells from early to late senescence: Changes in SASP composition and anti-tumour properties.
Alessio N; Acar MB; Squillaro T; Aprile D; Ayaz-Güner Ş; Di Bernardo G; Peluso G; Özcan S; Galderisi U
Cell Prolif; 2023 Jun; 56(6):e13401. PubMed ID: 36949664
[TBL] [Abstract][Full Text] [Related]
14. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).
Malaquin N; Rodier F
Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239
[TBL] [Abstract][Full Text] [Related]
15. Targeting Cellular Senescence with Senotherapeutics: Development of New Approaches for Skin Care.
Thompson EL; Pitcher LE; Niedernhofer LJ; Robbins PD
Plast Reconstr Surg; 2022 Oct; 150():12S-19S. PubMed ID: 36170431
[TBL] [Abstract][Full Text] [Related]
16. Cellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies.
Lucas V; Cavadas C; Aveleira CA
Pharmacol Rev; 2023 Jul; 75(4):675-713. PubMed ID: 36732079
[TBL] [Abstract][Full Text] [Related]
17. Senescent Cells in Cancer: Wanted or Unwanted Citizens.
Niklander SE; Lambert DW; Hunter KD
Cells; 2021 Nov; 10(12):. PubMed ID: 34943822
[TBL] [Abstract][Full Text] [Related]
18. Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing Strategies.
Calabrò A; Accardi G; Aiello A; Caruso C; Galimberti D; Candore G
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339070
[TBL] [Abstract][Full Text] [Related]
19. Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations.
Schafer MJ; Haak AJ; Tschumperlin DJ; LeBrasseur NK
Curr Rheumatol Rep; 2018 Jan; 20(1):3. PubMed ID: 29374361
[TBL] [Abstract][Full Text] [Related]
20. The Potential Role and Therapeutic Relevance of Cellular Senescence in Skeletal Pathophysiology.
Li B; Lyu P; Tang J; Li J; Ouchi T; Fan Y; Zhao Z; Li L
J Gerontol A Biol Sci Med Sci; 2024 Apr; 79(4):. PubMed ID: 38306619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
